Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Cash & Equivalents (2016 - 2023)

Historic Cash & Equivalents for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $93.2 million.

  • Cellectis' Cash & Equivalents fell 4978.56% to $93.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $93.2 million, marking a year-over-year decrease of 4978.56%. This contributed to the annual value of $93.2 million for FY2022, which is 4978.56% down from last year.
  • As of Q3 2023, Cellectis' Cash & Equivalents stood at $93.2 million, which was down 4978.56% from $93.2 million recorded in Q2 2023.
  • Cellectis' 5-year Cash & Equivalents high stood at $451.5 million for Q2 2019, and its period low was $83.5 million during Q1 2023.
  • Over the past 5 years, Cellectis' median Cash & Equivalents value was $241.1 million (recorded in 2020), while the average stood at $229.9 million.
  • Per our database at Business Quant, Cellectis' Cash & Equivalents surged by 7461.54% in 2019 and then tumbled by 4978.56% in 2022.
  • Over the past 5 years, Cellectis' Cash & Equivalents (Quarter) stood at $340.5 million in 2019, then decreased by 29.18% to $241.1 million in 2020, then decreased by 23.02% to $185.6 million in 2021, then tumbled by 49.79% to $93.2 million in 2022, then changed by 0.0% to $93.2 million in 2023.
  • Its Cash & Equivalents was $93.2 million in Q3 2023, compared to $93.2 million in Q2 2023 and $83.5 million in Q1 2023.